Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA.
Aliment Pharmacol Ther. 2009 Sep 15;30(6):670-80. doi: 10.1111/j.1365-2036.2009.04078.x. Epub 2009 Jun 25.
The Gastroparesis Cardinal Symptom Index (GCSI) is a patient-reported outcome for gastroparesis using a two-week recall period. To minimize potential patient recall effects, a daily diary version of the GCSI (GCSI-DD) was developed.
To evaluate the content validity of GCSI-DD for the symptoms in patients with documented gastroparesis, to capture symptom variability over time and to compare responses of this GCSI-DD to the original GCSI.
In gastroparesis adults with delayed gastric emptying, cognitive debriefing interviews were conducted to elicit their perspective on relevant symptoms of gastroparesis and relevant recall periods and to evaluate patient understanding of GCSI-DD. Patients completed the GCSI-DD daily over a 2-week period and completed the GCSI at baseline and the 2-week follow-up visit.
Twelve gastroparesis patients, of whom five were diabetic and nine women, reported nausea (100%), vomiting (100%), stomach fullness (75%), bloating (58%) and loss of appetite (50%) were important symptoms. All patients understood diary instructions and item content and reported that the diary captured their gastroparesis symptom experience; 83% considered response scales adequate. There was significant daily variability in GCSI-DD scores. Mean GCSI-DD subscale and total scores over 2 weeks correlated strongly (all r > 0.90) with GCSI scores at 2-week follow-up.
The GCSI-DD includes symptoms relevant to patients with gastroparesis, captures daily variability of those symptoms and has psychometric properties consistent with a good patient-reported outcome endpoint for gastroparesis clinical trials.
胃轻瘫综合症状指数(GCSI)是一种使用两周回顾期的胃轻瘫患者报告结局。为了最大程度地减少潜在的患者回忆效应,开发了 GCSI 的日常日记版本(GCSI-DD)。
评估 GCSI-DD 对有记录的胃轻瘫患者症状的内容效度,捕捉随时间推移的症状变化,并比较该 GCSI-DD 与原始 GCSI 的反应。
在患有胃排空延迟的胃轻瘫成年人中,进行认知性访谈,以了解他们对胃轻瘫相关症状和相关回顾期的看法,并评估患者对 GCSI-DD 的理解。患者在两周内每天完成 GCSI-DD,并在基线和两周随访时完成 GCSI。
12 名胃轻瘫患者(其中 5 名为糖尿病患者,9 名为女性)报告恶心(100%)、呕吐(100%)、胃部饱满(75%)、腹胀(58%)和食欲不振(50%)是重要症状。所有患者都理解日记说明和项目内容,并报告说日记记录了他们的胃轻瘫症状体验;83%的患者认为反应量表足够。GCSI-DD 评分每天都有显著的变化。两周内 GCSI-DD 子量表和总分与两周随访时的 GCSI 评分高度相关(所有 r > 0.90)。
GCSI-DD 包括与胃轻瘫患者相关的症状,可捕捉这些症状的日常变化,具有与胃轻瘫临床试验良好的患者报告结局终点相一致的心理测量特性。